The Discovery and Preclinical Development of ASG-5ME, an Antibody-Drug Conjugate Targeting SLC44A4-Positive Epithelial Tumors Including Pancreatic and Prostate Cancer (Q38733994)
Jump to navigation
Jump to search
scientific article published on 22 August 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The Discovery and Preclinical Development of ASG-5ME, an Antibody-Drug Conjugate Targeting SLC44A4-Positive Epithelial Tumors Including Pancreatic and Prostate Cancer |
scientific article published on 22 August 2016 |
Statements
1 reference
The Discovery and Preclinical Development of ASG-5ME, an Antibody-Drug Conjugate Targeting SLC44A4-Positive Epithelial Tumors Including Pancreatic and Prostate Cancer (English)
1 reference
Michael Mattie
1 reference
Arthur Raitano
1 reference
Kendall Morrison
1 reference
Karen Morrison
1 reference
Zili An
1 reference
Linnette Capo
1 reference
Alla Verlinsky
1 reference
Monica Leavitt
1 reference
Jimmy Ou
1 reference
Rossana Nadell
1 reference
Hector Aviña
1 reference
Claudia Guevara
1 reference
Faisal Malik
1 reference
Ruth Moser
1 reference
Steven Duniho
1 reference
Jeffrey Coleman
1 reference
Ying Li
1 reference
Daniel S Pereira
1 reference
Fernando Doñate
1 reference
Ingrid B J Joseph
1 reference
Pia Challita-Eid
1 reference
Dennis Benjamin
1 reference
David R Stover
1 reference
22 August 2016
1 reference
1 reference
15
1 reference
11
1 reference
2679-2687
1 reference
Identifiers
1 reference
1 reference